Alexion Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAlexion Pharmaceuticals

Alexion Pharmaceuticals(ALXN)

Alexion Pharmaceuticals is an American pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases. It became an independent subsidiary of AstraZeneca in 2021.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Kanuma	Sebelipase alfa	2015-12-08		Inborn errors lipid metabolism
Soliris	Eculizumab	2007-03-16		Paroxysmal hemoglobinuria , Myasthenia gravis , Atypical hemolytic uremic syndrome
Strensiq	Asfotase alfa	2015-10-23		Hypophosphatasia
Ultomiris	Ravulizumab	2018-12-21		Paroxysmal hemoglobinuria, Atypical hemolytic uremic syndrome

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

hypophosphatasia

Sebelipase alfa

mucopolysaccharidosis iv

,

mucopolysaccharidosis vi

,

glycogen storage disease type ii

,

sudden infant death

,

mucopolysaccharidosis vii

,

gaucher disease

,

,

cholesterol ester storage disease

,

,

failure to thrive

healthy volunteers/patients

,

,

end stage liver disease

,

,

vascular diseases

,

kidney diseases

,

glomerulonephritis

,

membranoproliferative glomerulonephritis

,

,

,

chronic kidney failure

,

,

anti-neutrophil cytoplasmic antibody-associated vasculitis

,

,

,

multiple organ failure

,

diabetes mellitus

,

thrombocytopenia

,

complement activation

,

psychology rejection

,

renal insufficiency

,

wounds and injuries

,

reperfusion injury

,

chronic renal insufficiency

,

hemolytic anemia autoimmune

,

,

antiphospholipid syndrome

,

macular degeneration

,

geographic atrophy

,

,

dermatomyositis

,

autoimmune diseases

,

anti-glomerular basement membrane disease

,

myasthenia gravis

,

kidney transplantation

,

muscle weakness

,

thrombotic microangiopathies

,

guillain-barre syndrome

,

delayed graft function

,

,

escherichia coli infections

,

left ventricular dysfunction

,

ventricular dysfunction

,

shiga-toxigenic escherichia coli

,

,

,

malignant hypertension

,

hypertensive crisis

,

phenylketonurias

,

,

paroxysmal hemoglobinuria

,

,

,

,

hemolytic-uremic syndrome

,

atypical hemolytic uremic syndrome

,

neuromyelitis optica

,

,

,

coronavirus infections

,

respiratory distress syndrome

,

,

acute lung injury

,

multiple sclerosis

,

magnetic resonance imaging

,

neuroinflammatory diseases

,

hypophosphatasia

,

severe acute respiratory syndrome

,

viral pneumonia

,

,

newborn respiratory distress syndrome

,

,

protein-losing enteropathies

,

intestinal diseases

,

,

lymphangiectasis

,

intestinal lymphangiectasis

,

,

disease progression

,

intestinal obstruction

,

,

allergic fungal sinusitis

,

,

healthy volunteers/patients

,

hepatic insufficiency

,

renal insufficiency

,

glomerulonephritis

,

membranoproliferative glomerulonephritis

,

,

geographic atrophy

,

paroxysmal hemoglobinuria

,

,

,

Mycophenolate sodium

autoimmune diseases

anxiety disorders

,

healthy volunteers/patients

,

,

,

acquired immunodeficiency syndrome

,

,

bacterial infections

,

depressive disorder

,

drug interactions

,

breast neoplasms

,

,

atherosclerosis

,

,

type 2 diabetes mellitus

,

,

urinary tract infections

,

,

mental disorders

non-hodgkin lymphoma

,

ulcerative colitis

,

,

,

,

,

rheumatoid arthritis

,

,

pharmacokinetics

,

,

multiple myeloma

,

plasma cell neoplasms

,

,

,

,

,

diffuse intrinsic pontine glioma

,

optic nerve glioma

,

brain stem neoplasms

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

,

healthy volunteers/patients

,

,

peptic esophagitis

,

peripheral arterial disease

,

b-cell lymphoma marginal zone

,

follicular lymphoma

,

mantle-cell lymphoma

,

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

,

communicable diseases

,

,

,

gastroenteritis

,

,

non-erosive reflux disease

,

,

gastroesophageal reflux

,

sleep initiation and maintenance disorders

,

sleep wake disorders

,

,

atrial fibrillation

,

venous thromboembolism

,

thromboembolism

,

,

,

sudden death cardiac

,

,

b-cell chronic lymphocytic leukemia

,

,

hodgkin disease

,

b-cell lymphoma

,

t-cell lymphoma cutaneous

,

bronchiolitis obliterans syndrome

,

,

t-cell lymphoma

,

follicular lymphoma

,

,

large-cell lymphoma anaplastic

,

t-cell lymphoma peripheral

,

non-hodgkin lymphoma

myocardial infarction

,

,

inferior wall myocardial infarction

,

coronary artery disease

,

cardiopulmonary bypass

,

coronary artery bypass

,

,

,

chronic hepatitis b

,

,

chronic hepatitis

,

Choline alfoscerate

,

,

coronary disease

,

type 2 diabetes mellitus

,

glucose metabolism disorders

,

metabolic diseases

,

diabetes mellitus

,

endocrine system diseases

,

,

neuroendocrine tumors

multiple myeloma

,

b-cell chronic lymphocytic leukemia

,

plasma cell neoplasms

,

hodgkin disease

,

,

breast neoplasms

,

,

mucinous adenocarcinoma

,

ductal carcinoma breast

,

inflammatory breast neoplasms

,

non-hodgkin lymphoma

,

mantle-cell lymphoma

,

,

squamous cell carcinoma of head and neck

,

squamous cell carcinoma

1

2

3

4

5

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use